Filtration In Biopharmaceutical Development & Manufacturing

 

Pharmaceutical formulations, drug products, therapies, vaccines and the processes by which they are made are becoming increasingly diverse. Whether used for clarification or sterilization of final material, filtration remains an essential part of them.

 

In this presentation, Tom Watson talks about Pall’s range of filters including carbon removal filters, sterilizing grade filters (liquid and air/gas applications) and pre-filters for different types of drugs and manufacturing processes.

 

You will also understand how Pall Biotech is continuing to innovate in the field of prefiltration and sterilizing grade filtration in response to evolving regulatory standards and changes in drug classes.

 

Participants will learn about:

 

  • How to select a right filter for your product and process.
  • What’s new in the pre-filtration and sterilizing grade filtration.
  • Integrity testing of hydrophilic and hydrophobic filters.

Speaker

tom watson

Tom Watson

Global Product Manager, Sterilizing Grade Filters

Pall Biotech

 

Tom joined Pall in 2003, having graduated from the University of Sheffield, UK with a degree in Biotechnology and Microbiology. Following several years as an Account Manager, in 2010 he joined the Global Product Marketing first as Global Product Manager, Sterilizing-grade Filters and is now marketing group leader for Sterilizing grade filters, test instruments and systems.

Filtration In Biopharmaceutical Development & Manufacturing

icon image

Prepare for a Successful Validation of Liposome-Based Drugs

Download this guide to get recommendations for applying QbD principles for sterility assurance during aseptic processing

More Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
November 2020

From November 3rd to November 19th

 

There is no single vaccine manufacturing approach. There are, however, flexible technologies that can meet each of the challenges during process development and at GMP scale.

 

Accelerating vaccine development and manufacturing by coupling research advances in vaccine technology with systems that support agility through a Quality by Design approach is critical to deliver life-saving immunizations to those in need globally.

 

Diversity in the type of vaccine antigen, along with the inherent variation in the targets, have created challenges for vaccine manufacturers when compared to a relatively small number of platform processes that exist.

 

There are flexible technologies that can meet each of the challenges during PD and at GMP scale.

 

Join this webinar series and learn more about securing process quality with flexible manufacturing solutions.

 

Webinars available

 

  • Vaccines development, regulations and manufacturing Parts 1 & 2

 

  • Developing scalable upstream workflows for recombinant and viral vaccine processes

 

  • Downstream process development for vaccine manufacturing

 

  • Implementing single-use technologies in formulation and filling of vaccines
Register